Rhythm Biosciences Limited (ASX:RHYOA)

Australia · Delayed Price · Currency is AUD

0.0260

-0.0040 (-13.33%)

At close: Jun 25, 2026

160.00% (1Y)

Market Cap	35.39M +111.1%
Revenue (ttm)	1.65M -48.0%
Net Income	-6.68M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	339,095
Open	0.0300
Previous Close	0.0300
Day's Range	0.0260 - 0.0300
52-Week Range	0.0080 - 0.1300
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Rhythm Biosciences

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances

Founded 2017

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol RHYOA

Financial Performance

In fiscal year 2025, Rhythm Biosciences's revenue was 3.19 million, an increase of 88.85% compared to the previous year's 1.69 million. Losses were -3.83 million, -44.15% less than in 2024.

Financial Statements